Veradigm Inc. (NASDAQ:MDRX – Get Free Report) shares gapped up before the market opened on Tuesday . The stock had previously closed at $9.65, but opened at $9.99. Veradigm shares last traded at $9.80, with a volume of 215,925 shares.
Wall Street Analyst Weigh In
Several research firms have commented on MDRX. StockNews.com started coverage on Veradigm in a report on Saturday, July 20th. They set a “hold” rating on the stock. TD Cowen lowered their price target on Veradigm from $26.00 to $15.00 and set a “buy” rating for the company in a research report on Tuesday, May 28th. Four equities research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. According to MarketBeat, the company currently has an average rating of “Hold” and a consensus target price of $12.00.
Check Out Our Latest Report on MDRX
Veradigm Price Performance
Hedge Funds Weigh In On Veradigm
Large investors have recently bought and sold shares of the business. TFO Wealth Partners LLC raised its holdings in Veradigm by 105,280.0% in the 4th quarter. TFO Wealth Partners LLC now owns 5,269 shares of the software maker’s stock worth $52,000 after purchasing an additional 5,264 shares during the period. Gladius Capital Management LP increased its stake in Veradigm by 135.0% during the 4th quarter. Gladius Capital Management LP now owns 6,245 shares of the software maker’s stock worth $66,000 after buying an additional 3,587 shares in the last quarter. Headlands Technologies LLC increased its stake in Veradigm by 14,907.7% during the 4th quarter. Headlands Technologies LLC now owns 9,755 shares of the software maker’s stock worth $102,000 after buying an additional 9,690 shares in the last quarter. Meadow Creek Wealth Advisors LLC purchased a new stake in Veradigm during the 1st quarter worth approximately $83,000. Finally, Forest Hill Capital LLC purchased a new stake in shares of Veradigm in the fourth quarter valued at approximately $210,000.
About Veradigm
Veradigm Inc, a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.
See Also
- Five stocks we like better than Veradigm
- How to Capture the Benefits of Dividend Increases
- Viking Therapeutics: Pharma Stock Soars on Positive Earnings
- Should You Add These Warren Buffett Stocks to Your Portfolio?
- Top 3 Small Cap Stocks Emerging as Rotation Winners
- How to Start Investing in Real Estate
- Bargain Alert: 3 Stocks Worth Watching While The Market Cools
Receive News & Ratings for Veradigm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veradigm and related companies with MarketBeat.com's FREE daily email newsletter.